Small- and medium-sized enterprises (SMEs) are powerhouses of the economy, and they drive industrial growth and job creation in Europe. IMI brings SMEs into our projects to bridge the gap between universities and pharma giants, giving them access to their target market, which can help them find out ways to make their product better. SMEs might join a project simply to offer a service that the consortium needs, or they might want to explore ways in which their technology, developed for one particular use, might be applied in another way. Another big draw for SMEs is the direct route to the regulators. Some IMI projects have even resulted in new commercial entities.